title: Gout in Aotearoa New Zealand: are we going to ignore this for another 3 years?
authors.affiliation: Rheumatologist and Professor, Bone and Joint Research Group, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland. n.dalbeth@auckland.ac.nz.
authors.forename: Nicola
authors.initials: N
authors.lastname: Dalbeth
authors.forename: Peter
authors.initials: P
authors.lastname: Gow
authors.forename: Gary
authors.initials: G
authors.lastname: Jackson
authors.forename: Carl
authors.initials: C
authors.lastname: Shuker
authors.forename: Leanne
authors.initials: L
authors.lastname: Te Karu
authors.forename: Catherine
authors.initials: C
authors.lastname: Gerard
authors.forename: Doone
authors.initials: D
authors.lastname: Winnard
mesh_terms: D006073:Gout / Q000188:drug therapy / Q000208:ethnology*; D006074:Gout Suppressants / Q000627:therapeutic use; D054624:Health Status Disparities; D054625:Healthcare Disparities / Q000208:ethnology* / Q000706:statistics & numerical data / Q000639:trends; D006801:Humans; D009520:New Zealand / Q000453:epidemiology
chemical_list: D006074:Gout Suppressants